台湾中药产业发展研究
[Abstract]:Humans have been around for millions of years, and it may not be easy to notice today that the average life expectancy has almost doubled over the past century. Since the advent of aspirin in 1897, the birth of western medicine has extended human life and improved the quality of life. The development of Western medicine today, there are still many diseases can not be done, the treatment of some diseases are not satisfactory, and the abuse of antibiotics has been a human problem. Traditional Chinese medicine has a long history, the global trend of thought of returning to nature to expand the market of traditional Chinese medicine. Traditional Chinese medicine (TCM) in Taiwan is of the same ancestry with the mainland of China. The development of traditional Chinese medicine (TCM) is fast in recent years, and the development of biotechnology has made the Chinese medicine industry have a broad prospect. Biotechnology is seen as Taiwan's next star industry, traditional Chinese medicine is one of the more promising areas, Taiwan's government fully supports the Chinese herbal medicine industry. This study is about the development of traditional Chinese medicine industry in Taiwan. Through the industrial analysis theory SWOT analysis, five-force analysis and value chain analysis to analyze the development of traditional Chinese medicine in Taiwan and its advantages and problems, and put forward relevant suggestions. The content of the article is divided into six parts: the first part is the introduction, mainly introduces the research background, the significance and the literature discussion, the second part introduces the international traditional Chinese medicine industry overall development situation; The third part introduces the structure of Taiwan's traditional Chinese medicine industry, including the development of Taiwan's traditional Chinese medicine industry, policies and pharmaceutical technology; The fourth part analyzes the advantages and disadvantages of Taiwan's traditional Chinese medicine industry and its competitiveness through SWOT analysis and five-force analysis, and the fifth part analyzes the value chain of Taiwan's traditional Chinese medicine industry, and puts forward the existing problems and solutions. The sixth part is the conclusion and the countermeasure and suggestion to promote the development of traditional Chinese medicine industry in Taiwan. The study found that although Taiwan's traditional Chinese medicine industry has some advantages over mainland China's management and R & D strength, the development of Taiwan's traditional Chinese medicine industry is still characterized by unstable quality of medicinal materials, uneven investment in scientific research, and imperfect laws and regulations. The enterprise scale is small and medium-sized, the marketing channel is mainly for the domestic sale and so on question. In view of the problems existing in Taiwan's traditional Chinese medicine industry, this paper puts forward some countermeasures and suggestions: strengthening cross-strait cooperation in traditional Chinese medicine industry to ensure the stability of Taiwan's traditional Chinese medicine quality, attaching importance to the cultivation of Taiwan's traditional Chinese medicine talents, and improving the level of traditional Chinese medicine research and development; Improve the laws and regulations of traditional Chinese medicine in Taiwan, build a good industrial environment, realize the protection of patent of Chinese medicine; perfect the financial service system of traditional Chinese medicine industry, merge the small and medium-sized enterprises of Chinese medicine to improve the competitiveness; broaden the marketing channels of traditional Chinese medicine and vigorously develop health care products of traditional Chinese medicine. It is advantageous for Taiwan to adapt to the trend of development of traditional Chinese medicine in the world and accelerate the modernization and internationalization of traditional Chinese medicine industry.
【学位授予单位】:福建农林大学
【学位级别】:硕士
【学位授予年份】:2013
【分类号】:F426.72;R288
【参考文献】
相关期刊论文 前10条
1 黄传慧;郑彦宁;吴春玉;;美国科技成果转化机制研究[J];湖北社会科学;2011年10期
2 郑少红;董剑程;;台湾农业科技成果转化系统的分析与思考[J];福建农林大学学报(哲学社会科学版);2009年06期
3 翁志辉;曾玉荣;吴立增;朱祥枝;王文烂;;台湾农业科技成果转化体系与机制研究[J];福建农业学报;2007年04期
4 孙波;;中药产品对外贸易的若干问题探讨[J];国际经贸探索;2009年09期
5 王艳花;李京芮;闫伟华;李林茜;;中药材种植农户参与订单合同的销售行为分析[J];贵州农业科学;2012年09期
6 黄清河;陈纪鹏;陈震文;;GAP认证面临的问题及对策[J];海峡药学;2007年10期
7 张冬;;中药知识产权国际化保护问题的实效方法论应用——以中美对中药保护最佳路径选择为视角[J];河北法学;2012年01期
8 李孔岳;;科技成果转化的模式比较及其启示[J];科技管理研究;2006年01期
9 熊俊莉;;“产业搭桥”为两岸新型产业合作奠基[J];两岸关系;2010年04期
10 李全新;李瑞青;;中药加工业优先发展的理论分析与对策[J];西北农林科技大学学报(社会科学版);2006年04期
相关博士学位论文 前3条
1 郝刚;我国中药产业发展策略研究[D];华中科技大学;2011年
2 黎日隆;中药知识管理与信息技术系统模型[D];华中科技大学;2006年
3 王广平;中药产业国际化进程中的影响因素分析与发展研究[D];暨南大学;2009年
相关硕士学位论文 前4条
1 赵卫红;中药产业国际化与知识产权保护[D];华中科技大学;2004年
2 肖伶俐;我国中药出口中的技术性贸易壁垒[D];吉林大学;2006年
3 邓泽辉;中药出口欧盟市场的困境及营销对策研究[D];暨南大学;2007年
4 陈莉;中国中药材产业化经营模式研究[D];西南石油大学;2007年
本文编号:2364174
本文链接:https://www.wllwen.com/guanlilunwen/shengchanguanlilunwen/2364174.html